Arrigo F.G. Cicero: Bempedoic Acid and Venous Thromboembolism Risk
Arrigo F.G. Cicero, Head of the Clinical Lipidology and Cardiovascular Prevention Laboratory at the University of Bologna, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Cardiology, adding:
“Pleased to share our newly published Letter in JAMA Cardiology: ‘Venous Thromboembolism Risk and Lipid-Lowering Therapy.’
Prompted by the intriguing 42% relative reduction in venous thromboembolism observed with bempedoic acid in a post hoc analysis of the CLEAR Outcomes trial, we discuss a broader perspective on lipid-lowering therapy.
Perhaps we should communicate these treatments not simply as a way to ‘lower cholesterol,’ but as part of a broader strategy for vascular protection.
This distinction matters – scientifically, clinically, and also in the way we engage with our patients.”
Title: Venous Thromboembolism Risk and Lipid-Lowering Therapy
Authors: Federica Fogacci, Ivan Pecin, Arrigo F. G. Cicero
Stay updated with Hemostasis Today.
-
Aug 28, 2026, 14:52Jessica Lee: Standing Together for Children and Families with Bleeding Disorders
-
Aug 28, 2026, 14:45Daisy Souster: A New Chapter in Bleeding Disorder Advocacy
-
Aug 28, 2026, 14:42Oluwatoyin Iyabode Ajayi: Heavy Periods – When Is Menstrual Bleeding Too Much?
-
Aug 28, 2026, 14:20Alyson Reidy: Factor Man and Community Support Take Center Stage at NBDF 2026
-
Aug 28, 2026, 14:09New Study Highlights Pregnancy Challenges in Inherited Bleeding Disorders – Glanzmann’s Research Foundation
-
Aug 28, 2026, 13:55Swatee C: A Guide to Common Uterine Disorders
-
Aug 28, 2026, 12:14Gathoni Kungu: Run to End Postpartum Hemorrhage and Save Lives
-
Aug 28, 2026, 12:09Joe Daniels: Heavy Periods Deserve Attention
-
Aug 28, 2026, 12:06Matthew Siedhoff: Understanding the Cause Behind Gynecological Symptoms